產(chǎn)品詳情
簡(jiǎn)單介紹:
CHIR99021
詳情介紹:
Characteristics | A potent and highly selective inhibitor of glycogen synthase kinase-3beta (GSK-3beta) (IC50 = 6.7 nM). CHIR99021 has been shown to allow for long-term expansion of murine embryonic stem cells in a chemically-defined medium in conjunction with MEK/MAPK inhibitor PD184352 and fibroblast growth factor receptor (FGFR) inhibitor SU5402. |
Purity | ≥ 98?% by HPLC |
Chemical Name | 6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile; CT99022 |
Formula | C??H??Cl?N? |
Permeability | Cell-permeable |
Molecular Weight | 465.34 g/mol |
CAS-No | 252917-06-9 |
Restrictions | For Research Use only |
Format | Solid |
Handling Advice | Protect from air and moisture |
Storage | -20 °C |
Expiry Date | 24 months |
Supplier Images |
|
Product cited in: |
Pour, Pilzer, Rosner, Smith, Meissner, Nachman: "Epigenetic predisposition to reprogramming fates in somatic cells." in: EMBO reports, Vol. 16, Issue 3, pp. 370-8, 2015 (PubMed).
Gerbal-Chaloin, Dumé, Briolotti, Klieber, Raulet, Duret, Fabre, Ramos, Maurel, Daujat-Chavanieu: "The WNT/β-catenin pathway is a transcriptional regulator of CYP2E1, CYP1A2, and aryl hydrocarbon receptor gene expression in primary human hepatocytes." in: Molecular pharmacology, Vol. 86, Issue 6, pp. 624-34, 2014 (PubMed). Zhao, Li, Trilok, Tanaka, Jokubaitis-Jameson, Wang, Niwa, Nakayama: "Small molecule-directed specification of sclerotome-like chondroprogenitors and induction of a somitic chondrogenesis program from embryonic stem cells." in: Development (Cambridge, England), Vol. 141, Issue 20, pp. 3848-58, 2014 (PubMed). Zhou, Katsman, Dhaliwal, Davidson, Macpherson, Sakthidevi, Collura, Mitchell: "A Sox2 distal enhancer cluster regulates embryonic stem cell differentiation potential." in: Genes & development, Vol. 28, Issue 24, pp. 2699-711, 2014 (PubMed). Abujarour, Bennett, Valamehr, Lee, Robinson, Robbins, Le, Lai, Flynn: "Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery." in: Stem cells translational medicine, Vol. 3, Issue 2, pp. 149-60, 2014 (PubMed). |